Idexx Laboratories (IDXX) Stock Price, Quote & News

Company Profile

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 207 556 0300

Fax: 207 556 4346

Website: www.idexx.com

Address:

One IDEXX Drive, Westbrook, United States

MyChicago Jul. 20 at 3:21 PM

$ZOMDF $ZTS $ELAN $IDXX. Animal health. Great Companies. Zomedica they are beginning their journey. Good time to buy.

0 · Reply

MyChicago Jul. 20 at 2:40 PM

$ZOMDF $ZOMDF $IDXX Johnny D. Powers didn’t just join Zomedica’s board back in 2019 — he planted himself there and stacked 4,410,000 SHARES like an absolute savage. This guy ran divisions at IDEXX, BD, Ventana, TriPath… and he’s loading ZOM like he already knows the ending. And he’s NOT alone. The insiders are buying like they’re preparing for a takeover. Kevin Klass (SVP) — the monster buyer Stacking millions of shares across repeated buys. Aggressive. Consistent. Zero hesitation. Larry Heaton (CEO) Multiple buys across years. Quiet but steady accumulation. CEOs don’t buy unless they see upside. Anthony Blair (COO) Another repeat buyer. Multiple transactions. Building a position, not trading noise. Directors Not sitting on the sidelines they’re loading too. This isn’t random. This isn’t retail hype. This is executive‑level conviction — across the board. When insiders buy together… When they buy repeatedly… When they buy MILLIONS… They’re positioning. $ZOMDF

0 · Reply

MyChicago Jul. 20 at 2:26 PM

$ZOMDF $IDXX Johnny D. Powers has been on Zomedica’s Board since 2019… and he’s not just sitting there he’s holding 4.41 MILLION SHARES. This isn’t a small bet. This is a conviction-sized position from a guy who ran major divisions at IDEXX, BD, Ventana, TriPath, literal industry royalty. Insiders don’t stack 4.4M shares for fun. They do it because they see what’s coming. They do it because they expect serious upside. They do it because they KNOW. ZOM’s leadership isn’t guessing they’re LOADING. Follow the money. Follow the conviction. $ZOMDF

0 · Reply

ETAlpha Jul. 12 at 3:20 PM

$ZTS Net Income skyrocketed 80% over 5 years, yet its valuation collapsed from 43x to 12x PE! A massive fundamental disconnect-is it a generational steal or a trap? Here are 3 more high-correlation veterinary/healthcare plays to watch: $IDXX : The pet diagnostics titan. High moat, experiencing a structural valuation reset alongside the sector. $ELAN : Animal health pure-play. Deeply corrected, now flashing solid baseline technical consolidation. $MRK : Pharma giant with huge animal health exposure. Elite cash flows and a top-tier defensive harbor. If you love spotting massive valuation gaps, smash that like and follow button right now! The complete sector deep-dive, live metrics, and our full market playbook are waiting on my profile.

0 · Reply

BillionerOfKing Jul. 7 at 10:59 PM

$IDXX Current Stock Price: $570.25 Contracts to trade: $570.0 IDXX Jul 17 2026 Call Entry: $9.80 Exit: $16.35 ROI: 67% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

iTrade_Price Jul. 4 at 8:35 PM

$IDXX monthly I D X X

0 · Reply

SuperGreenToday Jul. 2 at 11:07 AM

$IDXX Share Price: $537.65 Contract Selected: Dec 18, 2026 $530 Calls Buy Zone: $71.66 – $88.52 Target Zone: $124.62 – $152.31 Potential Upside: 64% ROI Time to Expiration: 168 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

txbondman Jun. 30 at 6:36 PM

bot $DVN, $HLI, $IDXX, $TKO, and $UTHR to double down; (Don't try this at home!!)

0 · Reply

EZ_Money11 Jun. 29 at 11:35 AM

$IDXX 👀

0 · Reply

BusinessStock Jun. 26 at 3:07 PM

$IDXX Go up not down

0 · Reply

IDEXX Laboratories to Release 2026 Second Quarter Financial Results

May 27, 2026, 10:55 AM EDT - 7 weeks ago

IDEXX Laboratories Transcript: Stifel Jaws & Paws Conference 2026

2026-05-26T12:01:58.000Z - 7 weeks ago

Idexx Laboratories expands Fecal Dx platform for taeniid tapeworm detection

May 26, 2026, 7:00 AM EDT - 7 weeks ago

IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection

2026-05-19T11:06:50.000Z - 2 months ago

Idexx Laboratories announces SDMA to be built into Catalyst CLIPs

May 19, 2026, 7:00 AM EDT - 2 months ago

IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles

May 14, 2026, 4:34 PM EDT - 2 months ago

IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day

May 12, 2026, 10:00 AM EDT - 2 months ago

IDEXX Laboratories Transcript: AGM 2026

2026-05-05T19:20:19.000Z - 2 months ago

Idexx Laboratories price target lowered to $660 from $790 at BofA

May 5, 2026, 8:30 AM EDT - 2 months ago

IDEXX Laboratories Earnings Call Transcript: Q1 2026

May 5, 2026, 8:30 AM EDT - 2 months ago

IDEXX Laboratories Earnings release: Q1 2026

May 5, 2026, 8:30 AM EDT - 2 months ago

IDEXX Laboratories Slides: Q1 2026

May 5, 2026, 8:30 AM EDT - 2 months ago

IDEXX Laboratories Quarterly report: Q1 2026

2026-05-05T10:53:57.000Z - 2 months ago

Idexx Laboratories reports Q1 EPS $3.47, consensus $3.41

2026-05-05T10:51:27.000Z - 2 months ago

Idexx Laboratories raises FY26 EPS view to $14.45-$14.90 from $14.29-$14.80

May 5, 2026, 6:30 AM EDT - 2 months ago

IDEXX Laboratories Announces First Quarter Results

2026-04-28T13:14:55.000Z - 2 months ago

Idexx Laboratories price target lowered to $640 from $730 at UBS

Apr 27, 2026, 11:40 AM EDT - 3 months ago

University of New England launches new Institute of Public and Planetary Health in honor of philanthropist and IDEXX Founder David Evans Shaw

2026-04-15T10:26:57.000Z - 3 months ago

Idexx Laboratories initiated with a Neutral at Citi

Apr 8, 2026, 1:00 PM EDT - 3 months ago

IDEXX Laboratories to Release 2026 First Quarter Financial Results

2026-04-01T09:15:31.000Z - 3 months ago

Idexx Laboratories announces Idexx Cancer Dx Panel availability in the UK

Apr 1, 2026, 3:00 AM EDT - 3 months ago

IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma

2026-03-31T10:44:57.000Z - 3 months ago

Idexx Laboratories price target lowered to $675 from $775 at Stifel

Mar 27, 2026, 8:00 AM EDT - 4 months ago

IDEXX Laboratories Proxy statement: Proxy filing

Mar 27, 2026, 8:00 AM EDT - 4 months ago

IDEXX Laboratories Proxy statement: Proxy filing

2026-03-26T19:45:14.000Z - 4 months ago

Idexx Laboratories management to meet with Piper Sandler

Mar 13, 2026, 8:00 AM EDT - 4 months ago

IDEXX Laboratories Proxy statement: Proxy Filing

Mar 2, 2026, 9:15 AM EST - 5 months ago

IDEXX Laboratories Transcript: 47th Annual Raymond James Institutional Investor Conference

Mar 2, 2026, 9:15 AM EST - 5 months ago

IDEXX Laboratories Slides: 47th Annual Raymond James Institutional Investor Conference

Feb 26, 2026, 9:50 AM EST - 5 months ago

IDEXX Laboratories Transcript: BofA Securities Animal Health Summit

Feb 12, 2026, 4:15 PM EST - 5 months ago

IDEXX Laboratories to Present at Two Institutional Investor Conferences

2026-02-09T11:55:29.000Z - 5 months ago

Idexx Laboratories price target lowered to $750 from $775 at Piper Sandler

2026-02-05T10:45:55.000Z - 5 months ago

Idexx Laboratories price target lowered to $800 from $850 at Barclays

2026-02-03T12:10:52.000Z - 5 months ago

Idexx Laboratories price target lowered to $730 from $750 at UBS

2026-02-03T02:10:10.000Z - 5 months ago

Idexx Laboratories price target lowered to $800 from $830 at BTIG

Feb 2, 2026, 8:30 AM EST - 6 months ago

IDEXX Laboratories Earnings Call Transcript: Q4 2025

Feb 2, 2026, 8:30 AM EST - 6 months ago

IDEXX Laboratories Annual report: Q4 2025

Feb 2, 2026, 8:30 AM EST - 6 months ago

IDEXX Laboratories Earnings release: Q4 2025

Feb 2, 2026, 8:30 AM EST - 6 months ago

IDEXX Laboratories Slides: Q4 2025

Feb 2, 2026, 8:12 AM EST - 6 months ago

IDEXX forecasts 2026 revenue, profit above estimates on strong demand for pet diagnostics

2026-02-02T11:35:45.000Z - 6 months ago

Idexx Laboratories reports Q4 EPS $3.08, consensus $2.94

Feb 2, 2026, 6:30 AM EST - 6 months ago

IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results

Jan 15, 2026, 7:15 AM EST - 6 months ago

Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus

Jan 15, 2026, 7:00 AM EST - 6 months ago

IDEXX Advances the Future of Veterinary Cancer Care with Comprehensive Mast Cell Tumor Testing for Dogs

Jan 13, 2026, 8:30 AM EST - 6 months ago

IDEXX Announces CEO Succession

Jan 9, 2026, 1:30 PM EST - 6 months ago

IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results

Jan 7, 2026, 1:51 PM EST - 6 months ago

Final Trades: Palo Alto Networks, Capital One, Idexx Labs and the XLB

COF PANW XLB

Nov 24, 2025, 2:15 PM EST - 8 months ago

IDEXX Laboratories Vs ResMed: Which Stock Could Rally?

RMD

Nov 3, 2025, 1:29 PM EST - 9 months ago

Final Trades: Meta, S&P Global and Idexx Lab

META SPGI

Nov 3, 2025, 11:08 AM EST - 9 months ago

Idexx Stock Pops on Earnings. Pet Health Is Booming.

Nov 3, 2025, 8:30 AM EST - 9 months ago

IDEXX Laboratories Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:30 AM EST - 9 months ago

IDEXX Laboratories Quarterly report: Q3 2025

Nov 3, 2025, 8:30 AM EST - 9 months ago

IDEXX Laboratories Earnings release: Q3 2025

Nov 3, 2025, 8:30 AM EST - 9 months ago

IDEXX Laboratories Slides: Q3 2025

Nov 3, 2025, 7:43 AM EST - 9 months ago

IDEXX raises annual forecasts as pet owners spend more on preventive care

Nov 3, 2025, 6:30 AM EST - 9 months ago

IDEXX Laboratories Announces Third Quarter Results

Oct 8, 2025, 2:00 PM EDT - 10 months ago

IDEXX Laboratories to Release 2025 Third Quarter Financial Results

Oct 7, 2025, 7:00 AM EDT - 10 months ago

IDEXX Laboratories Elects Karen Peacock to Board of Directors

Sep 9, 2025, 1:50 PM EDT - 11 months ago

IDEXX Laboratories Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 2, 2025, 1:00 PM EDT - 11 months ago

IDEXX Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 14, 2025, 8:00 AM EDT - 1 year ago

IDEXX Laboratories Transcript: Investor Day 2025

Aug 14, 2025, 8:00 AM EDT - 1 year ago

IDEXX Laboratories Slides: FY 2025

Aug 4, 2025, 5:55 PM EDT - 1 year ago

S&P 500 Gains and Losses Today: Retail Sector Stocks Rise Amid Rate Cut Hopes

Aug 4, 2025, 1:48 PM EDT - 1 year ago

Final Trades: Delta Air Lines, Tesla, Idexx Lab and the IYF

DAL IYF TSLA

Aug 4, 2025, 12:15 PM EDT - 1 year ago

Top Stock Movers Now: IDEXX, Wayfair, Berkshire Hathaway, and More

Aug 4, 2025, 9:10 AM EDT - 1 year ago

IDEXX Laboratories Stock Jumps as Pet Health Care Firm Lifts Full-Year Outlook

Aug 4, 2025, 8:30 AM EDT - 1 year ago

IDEXX Laboratories Earnings Call Transcript: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

IDEXX Laboratories Quarterly report: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

IDEXX Laboratories Earnings release: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

IDEXX Laboratories Slides: Q2 2025

Aug 4, 2025, 7:57 AM EDT - 1 year ago

IDEXX Laboratories raises annual forecasts on strong demand for pet diagnostics

Aug 4, 2025, 6:30 AM EDT - 1 year ago

IDEXX Laboratories Announces Second Quarter Results

Jul 30, 2025, 7:00 AM EDT - 1 year ago

IDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its Goals

Jul 10, 2025, 7:00 AM EDT - 1 year ago

IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors

Jun 24, 2025, 1:00 PM EDT - 1 year ago

IDEXX Laboratories to Release 2025 Second Quarter Financial Results

Jun 5, 2025, 7:00 AM EDT - 1 year ago

Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders

May 28, 2025, 10:55 AM EDT - 1 year ago

IDEXX Laboratories Transcript: Stifel Jaws & Paws Conference 2025

May 13, 2025, 2:30 PM EDT - 1 year ago

IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day

May 1, 2025, 8:30 AM EDT - 1 year ago

IDEXX Laboratories Earnings Call Transcript: Q1 2025

May 1, 2025, 8:30 AM EDT - 1 year ago

IDEXX Laboratories Quarterly report: Q1 2025

May 1, 2025, 8:30 AM EDT - 1 year ago

IDEXX Laboratories Earnings release: Q1 2025

May 1, 2025, 8:30 AM EDT - 1 year ago

IDEXX Laboratories Slides: Q1 2025

May 1, 2025, 8:21 AM EDT - 1 year ago

IDEXX Laboratories raises annual profit view on strong demand for its pet diagnostics

Apr 3, 2025, 1:30 PM EDT - 1 year ago

IDEXX Laboratories to Release 2025 First Quarter Financial Results

Mar 28, 2025, 8:00 AM EDT - 1 year ago

IDEXX Laboratories Proxy statement: Proxy Filing

Mar 28, 2025, 8:00 AM EDT - 1 year ago

IDEXX Laboratories Proxy statement: Proxy Filing

Mar 14, 2025, 8:00 AM EDT - 1 year ago

IDEXX Laboratories Proxy statement: Proxy Filing

Mar 3, 2025, 11:35 AM EST - 1 year ago

IDEXX Laboratories Transcript: Raymond James 46th Annual Institutional Investors Conference

Feb 27, 2025, 9:00 AM EST - 1 year ago

IDEXX Laboratories Transcript: BofA Securities Animal Health Summit 2025

Feb 13, 2025, 2:00 PM EST - 1 year ago

IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences

Feb 3, 2025, 11:31 AM EST - 1 year ago

Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today's Top S&P 500 Performers.

ABBV MOH

Feb 3, 2025, 11:22 AM EST - 1 year ago

IDEXX Laboratories Stock Jumps on Testing Products Demand, Higher Prices

Feb 3, 2025, 8:30 AM EST - 1 year ago

IDEXX Laboratories Earnings Call Transcript: Q4 2024

Feb 3, 2025, 8:30 AM EST - 1 year ago

IDEXX Laboratories Annual report: Q4 2024

Feb 3, 2025, 8:30 AM EST - 1 year ago

IDEXX Laboratories Earnings release: Q4 2024

Feb 3, 2025, 8:30 AM EST - 1 year ago

IDEXX Laboratories Slides: Q4 2024

Feb 3, 2025, 7:57 AM EST - 1 year ago

Animal diagnostics maker IDEXX beats quarterly estimates despite low vet visits

Feb 3, 2025, 6:30 AM EST - 1 year ago

IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results

Jan 16, 2025, 4:15 PM EST - 1 year ago

IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results

Dec 19, 2024, 10:09 AM EST - 1 year ago

SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX

SNPS

Dec 9, 2024, 7:30 AM EST - 1 year ago

IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization

Nov 21, 2024, 7:30 AM EST - 1 year ago

IDEXX Announces CFO Transition

Nov 12, 2024, 9:00 AM EST - 1 year ago

ACVIM and IDEXX Partner to Provide Free Educational Offerings for ACVIM Residents

Oct 31, 2024, 1:15 PM EDT - 1 year ago

CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results

Oct 31, 2024, 8:30 AM EDT - 1 year ago

IDEXX Laboratories Earnings Call Transcript: Q3 2024

Oct 31, 2024, 8:30 AM EDT - 1 year ago

IDEXX Laboratories Quarterly report: Q3 2024

Oct 31, 2024, 8:30 AM EDT - 1 year ago

IDEXX Laboratories Earnings release: Q3 2024

Oct 31, 2024, 8:30 AM EDT - 1 year ago

IDEXX Laboratories Slides: Q3 2024

Oct 31, 2024, 8:01 AM EDT - 1 year ago

IDEXX laboratories cuts annual revenue forecast for third time as pet clinic visits slow

Sep 30, 2024, 2:00 PM EDT - 1 year ago

IDEXX Laboratories to Release 2024 Third Quarter Financial Results

MyChicago Jul. 20 at 3:21 PM

$ZOMDF $ZTS $ELAN $IDXX. Animal health. Great Companies. Zomedica they are beginning their journey. Good time to buy.

0 · Reply

MyChicago Jul. 20 at 2:40 PM

0 · Reply

MyChicago Jul. 20 at 2:26 PM

0 · Reply

ETAlpha Jul. 12 at 3:20 PM

0 · Reply

BillionerOfKing Jul. 7 at 10:59 PM

0 · Reply

iTrade_Price Jul. 4 at 8:35 PM

$IDXX monthly I D X X

0 · Reply

SuperGreenToday Jul. 2 at 11:07 AM

0 · Reply

txbondman Jun. 30 at 6:36 PM

bot $DVN, $HLI, $IDXX, $TKO, and $UTHR to double down; (Don't try this at home!!)

0 · Reply

EZ_Money11 Jun. 29 at 11:35 AM

$IDXX 👀

0 · Reply

BusinessStock Jun. 26 at 3:07 PM

$IDXX Go up not down

0 · Reply

BillionerOfKing Jun. 26 at 12:34 AM

$IDXX Current Stock Price: $554.78 Contracts to trade: $550.0 IDXX Jul 17 2026 Call Entry: $17.60 Exit: $34.62 ROI: 97% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

SuperGreenToday Jun. 23 at 3:12 AM

$IDXX Share Price: $545.74 Contract Selected: Dec 18, 2026 $550 Calls Buy Zone: $61.12 – $75.50 Target Zone: $107.74 – $131.68 Potential Upside: 66% ROI Time to Expiration: 178 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

BusinessStock Jun. 22 at 7:27 PM

$IDXX Why down for no reason...

0 · Reply

BusinessStock Jun. 17 at 7:59 PM

$IDXX Rebound...

0 · Reply

AIBioScanner Jun. 8 at 7:58 AM

$IDXX AI-Based Findings on IDXX After running IDXX through my AI-driven quantitative framework, the stock is in a sideways/mixed trend with price trading near both moving averages with no clear directional pressure. IDXX is trading around $562.16, near both the 20-day (~$550.98) and 50-day (~$563.09) moving averages — indicating indecision and softening structure. Key signals: • Trading near both MAs — sideways/mixed trend • MACD negative (-0.26) — bearish momentum • Range between ~$528.68 support and ~$591.84 resistance 1-Month Outlook: Base scenario: consolidation near $534.05–$590.27 Breakout above $590.27 could open a move toward $690.61 Breakdown below $534.05 may extend further downside toward $437.92 Structure is neutral-to-mixed. Requires strong volume confirmation for any reversal. Not financial advice.$IDXX

0 · Reply

MarketBeat May. 30 at 11:02 AM

https://marketbeat.com/a/8683841/ $IDXX IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference

0 · Reply

BillionerOfKing May. 25 at 9:17 PM

$IDXX Current Stock Price: $559.38 Contracts to trade: $560.0 IDXX Jun 18 2026 Call Entry: $18.00 Exit: $24.97 ROI: 39% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Estimize May. 25 at 2:00 PM

Wall St is expecting 3.96 EPS for $IDXX Q2 [Reporting 08/04 BMO] http://www.estimize.com/intro/idxx?chart=historical&metric_name=eps&utm_co

0 · Reply

CapitalMonk May. 20 at 5:49 AM

$IDXX Price: $546.49 (+0.13%) Trend: Bearish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.99% RSI: 46.9 | Momentum: Moderate Volume: +11.3% vs avg Volatility: 2.03% Support: $523.38 | Resistance: $585.12 Sourch: http://marketbaubles.com/

0 · Reply

falcon_trader11 May. 18 at 6:15 PM

Not many small biotech names can reference relationships tied to $JNJ and $IDXX . $HYFT ecosystem keeps getting more interesting.

0 · Reply

bullishbears May. 13 at 5:30 PM

Veterinary stocks are gaining attention as pet ownership and animal healthcare spending continue to grow. Companies like Zoetis ($ZTS), IDEXX Laboratories ($IDXX), PetIQ ($PETQ), and Trupanion ($TRUP) are helping shape the future of the veterinary and pet care industry. From diagnostics and pharmaceuticals to pet insurance and wellness products, these stocks give investors exposure to a growing market driven by strong consumer demand and long-term trends. Check out our full breakdown of top veterinary stocks to watch and learn how traders and investors are approaching this sector. https://bullishbears.com/veterinary-stocks/

0 · Reply

MyChicago May. 13 at 4:02 PM

$ZOMDF Zomedica May Momentum CEO Larry Heaton and Johnny D Powers, both added shares in May 2026, direct insider confidence right after Zomedica reported record Q1 revenue of $8.8 million, up 35% YoY with $47.5 million in liquidity. Insiders don’t buy unless they believe in the next leg up. $IDXX $AMZN $ELAN

2 · Reply

Market Cap	44.76B
Revenue (ttm)	4.30B
Net Income (ttm)	1.06B
EPS (ttm)	N/A
PE Ratio	42.42
Forward PE	39.23
Profit Margin	24.62%
Debt to Equity Ratio	0.29

Volume	407,800
Avg Vol	675,768
Day's Range	N/A - N/A
Shares Out	78.88M
Stochastic %K	69%
Beta	1.55
Analysts	Strong Sell
Price Target	$720.14